ABSTRACT
In well over 200 patients treated to date at our institution, the great majority have had no complications (no VPI, infection, or symptomatic airway edema). Most describe a nonobstructing ‘‘lump’’ in their throat (injected site), which resolves in 2-5 days. There is relatively painless mucosal breakdown in themajority of patients within 5 days postprocedure, which has resolved in every case without sequelae. The injection should be placed slightly above the uvula to avoid uvular swelling. Four cases of soft palate fistula have occurred, all of which resolved quickly without intervention within 1week of identification. There have been no postinjection difficulties with speech production, swallowing, excessive scarring, or anaphylaxis to the sclerosing agents.
